Forbes J M & CO LLP Axsome Therapeutics, Inc. Transaction History
Forbes J M & CO LLP
- $1.01 Billion
- Q4 2024
A detailed history of Forbes J M & CO LLP transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 3,840 shares of AXSM stock, worth $433,612. This represents 0.03% of its overall portfolio holdings.
Number of Shares
3,840
Previous 3,840
-0.0%
Holding current value
$433,612
Previous $345,000
6.09%
% of portfolio
0.03%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
328Shares Held
38.1MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$473 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$451 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$373 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$266 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$118 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.84B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...